Fluticasone Ointment (Flutivate)
Canadian Meds |
Policy | Legal
Terms | Meds Index
Fluticasone Ointment is a local synthetic glucocorticoid (adrenal cortex hormones) drug used mainly for the treatment of dermatoses.
The drug has a pronounced anti-inflammatory, decongestant, anti-allergic and antipruritic properties. The active substance is represented by fluticasone, which has the ability to suppress an increase in the number of mast cells which are accumulated in the hearth of the inflammatory reaction, lymphocytes, eosinophils, neutrophils, macrophages, inhibit the synthesis and release of inflammatory mediators. Thus, as a result of medication action a reduction in the intensity of the inflammatory process, reduced congestion (increase of blood vessels), itching, burning are achieved. The recommended for external use doses have no significant effect on the central nervous, respiratory and cardiovascular systems.
The annotation recommends using the drug in case of eczema; contact dermatitis; seborrheic dermatitis; atopic dermatitis; lichen planus; neyrodermatozah, including the simple herpes; psoriasis; discoid lupus erythematosus; red prickly heat; erythroderma and insect bites.
Instructions for use
Fluticasone-based drugs are available in the form of creams and ointments, the main difference between them is the amount of active ingredient: Fluticasone Ointment contains 50 micrograms of fluticasone in 1g, while 1g of cream contains 500mcg. The cream can be used in adults, children and infants older than 3 months. The drug should be applied 1-2 times per day in a thin layer to the affected area. In order to reduce the likelihood of relapse in atopic eczema the ointment is administered two times per week, once a day before the affected areas. The ointment is applied in the same way as the cream. The maximum duration of the use of ointment is 4 weeks; however, if the clinical picture has not improved within 7 days of treatment, it is necessary to make adjustments to the scheme of therapy.
Warm and humid conditions, which tend to occur under occlusive dressings increases the risk of bacterial infections. So before you apply a new bandage, the skin should be thoroughly processed antiseptic. Long-term topical application of potent glucocorticoids causes atrophic changes most often on the face. This nuance should be considered in the treatment of diseases such as severe erythema, discoid lupus erythematosus, and psoriasis.
According to the instructions, the drug can cause adverse reactions such as: symptoms of Cushing (failure of some organs and systems, weight gain, decrease in the rate of growth, pigmentation, stretch marks, amenorrhea, muscle weakness, osteoporosis); flushing of the skin; hyperkeratosis, feeling of fever, pigmentation disorders, excessive hair growth, atrophic striae; dermatitis, hives, itchy skin; secondary infections of the skin. These side effects of the drug are rare and are usually preceded by the prolonged use of the medication. The risk of the emergence of symptoms of cushing should include children, applying occlusive dressing, infants, who may have the effect of bandage diapers and those using the drug in the vast areas of the skin/during the prolonged periods of time.
The ointment is not appointed in case of hypersensitivity to fluticasone, ordinary or pink acne, perianal and genital itching, perioral dermatitis, primary skin lesions of fungal, viral and bacterial etiology. In children under 3 months the use of the drug is contraindicated. The drug is recommended to be prescribed with caution to expectant mothers and women during lactation periods.
© 2003-2017 Rx Meds Canada . All Rights Reserved